Related Experiment Video
Updated: May 21, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Hormonal contraception and migraine: clinical considerations
Stephanie S Faubion1, Petra M Casey, Lynne T Shuster
1Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Women's Health Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. faubion.stephanie@mayo.edu
Current Pain and Headache Reports
|June 1, 2012
Summary
Migraine affects many women, especially during reproductive years. Hormonal contraceptives can help manage menstrual migraine without increasing stroke risk in healthy women.
Area of Science:
- Neurology
- Women's Health
- Reproductive Medicine
Background:
- Migraine is highly prevalent in women, particularly during their reproductive years.
- Preventive strategies for migraine are underutilized.
- Menstrual-related migraine poses a significant burden.
Purpose of the Study:
- To evaluate the dual benefit of hormonal contraceptives for women of reproductive age.
- To assess the safety of hormonal contraceptives in women with migraine, considering stroke risk.
Main Methods:
- Review of existing literature on migraine prevalence in women.
- Analysis of studies on the efficacy of hormonal contraceptives for migraine prevention.
- Examination of data regarding the association between hormonal contraceptives, migraine, and stroke risk.
Main Results:
- Hormonal contraceptives offer a dual benefit: contraception and reduction of menstrual migraine.
- Low-dose hormonal contraceptives do not appear to increase stroke risk in healthy women with migraine.
Conclusions:
- Hormonal contraceptives are a viable option for women of reproductive age experiencing migraine.
- The use of low-dose hormonal contraceptives should be considered for managing menstrual migraine in healthy women.
Related Concept Videos
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...